Evidence map›Paper›PMID 33236823›Full record

ReviewDermatologic therapy2021

Oral manifestations of COVID-19 disease: A review article.

Behzad Iranmanesh, Maryam Khalili, Rezvan Amiri, Hamed Zartab, Mahin Aflatoonian

Open access · greenAbstract readReview
In one paragraph

Review in Dermatologic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 7 pooled it
34.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 7 syntheses or guidelines pooled it, 268 citations in OpenAlex.

  1. Pooled it
  2. Oral mucosa lesions in confirmed and non-vaccinated cases for COVID-19: A systematic review.Journal of stomatology, oral and maxillofacial surgery · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  7. Oral mucosal lesions in patients with COVID-19: a systematic review.The British journal of oral & maxillofacial surgery · 2021
    Pooled it
  8. Trial
  9. Oral and maxillofacial manifestations of COVID-19.GMS hygiene and infection control · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Identification ofMolecules (Basel, Switzerland) · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Behzad IranmaneshDepartment of Dermatology, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0002-6892-4336
Maryam KhaliliDepartment of Dermatology, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0003-1866-7092
Rezvan AmiriDepartment of Dermatology, Kerman University of Medical Sciences, Kerman, Iran.
Hamed ZartabDepartment of Dermatology, Kerman University of Medical Sciences, Kerman, Iran.
Mahin AflatoonianLeishmaniasis Research Center, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0002-9373-8682
Kerman University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysgeusia is the first recognized oral symptom of novel coronavirus disease (COVID-19). In this review article, we described oral lesions of COVID-19 patients. We searched PubMed library and Google Scholar for published literature since December 2019 until September 2020. Finally, we selected 35 articles including case reports, case series and letters to editor. Oral manifestations included ulcer, erosion, bulla, vesicle, pustule, fissured or depapillated tongue, macule, papule, plaque, pigmentation, halitosis, whitish areas, hemorrhagic crust, necrosis, petechiae, swelling, erythema, and spontaneous bleeding. The most common sites of involvement in descending order were tongue (38%), labial mucosa (26%), and palate (22%). Suggested diagnoses of the lesions were aphthous stomatitis, herpetiform lesions, candidiasis, vasculitis, Kawasaki-like, EM-like, mucositis, drug eruption, necrotizing periodontal disease, angina bullosa-like, angular cheilitis, atypical Sweet syndrome, and Melkerson-Rosenthal syndrome. Oral lesions were symptomatic in 68% of the cases. Oral lesions were nearly equal in both genders (49% female and 51% male). Patients with older age and higher severity of COVID-19 disease had more widespread and sever oral lesions. Lack of oral hygiene, opportunistic infections, stress, immunosuppression, vasculitis, and hyper-inflammatory response secondary to COVID-19 are the most important predisposing factors for onset of oral lesions in COVID-19 patients.

Indexed as

COVID-19HumansMouth DiseasesSARS-CoV-2aphthousCOVID-19gingivostomatitismanifestationoral

Identifiers

PMID33236823
PMCPMC7744903
OpenAlexW3109319784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.